AB Pharma Consultancy Ltd NI688691 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is consultancy Digita Accounts Production Advanced 6.30.9574.0 true NI688691 2024-07-01 2025-06-30 NI688691 2025-06-30 NI688691 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 NI688691 bus:Micro-entities 2024-07-01 2025-06-30 NI688691 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 NI688691 bus:FullAccounts 2024-07-01 2025-06-30 NI688691 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 NI688691 bus:RegisteredOffice 2024-07-01 2025-06-30 NI688691 bus:Director1 2024-07-01 2025-06-30 NI688691 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 NI688691 countries:NorthernIreland 2024-07-01 2025-06-30 NI688691 2023-07-01 2024-06-30 NI688691 2024-06-30 NI688691 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 iso4217:GBP xbrli:pure

Registration number: NI688691

AB Pharma Consultancy Ltd

Annual Report and Unaudited Financial Statements

for the Year Ended 30 June 2025

 

AB Pharma Consultancy Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

AB Pharma Consultancy Ltd

Company Information

Director

Mrs Anna Murphy Beretta

Registered office

32 Oaklands
Newry
Down
BT34 2SS

 

AB Pharma Consultancy Ltd

(Registration number: NI688691)
Balance Sheet as at 30 June 2025

2025
£

2024
£

Fixed assets

3,811

3,811

Current assets

27,162

30,634

Creditors: Amounts falling due within one year

(572)

(3,519)

Net current assets

26,590

27,115

 

30,401

30,926

Capital and reserves

30,401

30,926

1

General information

The company is a private company limited by share capital, incorporated in Northern Ireland.

The address of its registered office is:
32 Oaklands
Newry
Down
BT34 2SS

These financial statements were authorised for issue by the director on 18 October 2025.

2

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime.

Approved and authorised by the director on 18 October 2025
 

.........................................
Mrs Anna Murphy Beretta
Director